Revenue for the fiscal year ended June 30, 2003 totaled $775,336 compared
to $549,198 in the prior year ended June 30, 2002. The Company incurred a
net loss of $3,802,381 for fiscal year 2003 or $.45 per share compared
with a net loss of $6,369,666 for fiscal year 2002 or $1.07 per share.
Included in the net loss for fiscal year 2003 are the following non-cash
expense charges: $400,000 for the fair value of common stock and warrants
issued to a firm for investor communications and public relations
consulting services; $165,136 in amortized debt discount relating to the
private placement of convertible debt ; and $850,000 in connection with
the creation of an inventory reserve allowance.
On August 28, 2003, the Company completed a private placement offering
(the “Offering”) to a group of investors led by Mark N. Schwartz. Gross
proceeds from this offering were approximately $2,300,000. The offering
involved the sale of units with each unit comprised of shares of the
Company’s Series A Convertible Preferred Stock, Common Stock and warrants
to acquire both Common and Series A Convertible Preferred Stock. The
Company sold a total of 585,980 Units. Simultaneously with the closing of
the Offering, the Company closed a transaction with its 8% Noteholders
pursuant to which they tendered their notes to the Company along with
accrued interest thereon totaling $529,980 for 3,238,767 shares of the
Company’s common stock.
Forward-looking statements in this press release are made under the safe
harbor provisions of the Private Securities Litigation Reform Act of 1995.
The Company wishes to caution readers not to place undue reliance on any
forward-looking statements and to recognize that the statements are not a
prediction of actual future results. Actual results could differ
materially from those presented and anticipated in the forward-looking
statements due to the risks and uncertainties set forth in the Company’s
2002 Annual Report on Form 10-KSB, as amended, and subsequent Quarterly
Reports on Form 10-QSB, all of which were filed with the U.S. Securities
and Exchange Commission, as well as others not now anticipated.
View PDF
file:
FY
2003 Results
CVProfilor is a registered trademark of Hypertension Diagnostics, Inc.
Hypertension Diagnostics, HDI/PulseWave, PulseWave and CVProfile are trademarks of
Hypertension Diagnostics, Inc. All rights reserved.